Home » Market News » DirectorsTalk Highlights » SARS-COV-2 Neutralising Affimer Reagents video presentation
Avacta Group Plc

SARS-COV-2 Neutralising Affimer Reagents video presentation

Alastair Smith gives a video presentation on their recent announcement – SARS-COV-2 Neutralising Affimer Reagents: Potential for a COVID-19 Affimer Therapy.

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.